IL6 and rheumatoid arthritis: A recent study (43) reports unchanged ex vivo responses to LPS between healthy donors and RA patients; the authors didn't identify an increase in H3K4me3 at IL6 and TNF promoters and therefore rejected the TI hypothesis in RA.